Workflow
天圣制药(002872) - 2025 Q3 - 季度财报
TSZYTSZY(SZ:002872)2025-10-29 10:05

Financial Performance - Q3 2025 revenue was CNY 116,617,256.62, a decrease of 3.57% year-over-year, and a decline of 13.31% compared to the beginning of the year[5] - Net profit attributable to shareholders was CNY -8,627,087.52, a decrease of 227.69% year-over-year, and CNY -45,339,431.49 for the year-to-date, down 24.72%[5] - Basic and diluted earnings per share were both CNY -0.0271, reflecting a decrease of 227.83% year-over-year[5] - Total operating revenue for the current period was CNY 348,810,958.38, a decrease of 13.3% compared to CNY 402,356,773.40 in the previous period[32] - The net profit for the current period is -45,769,255.29, compared to -37,080,882.01 in the previous period, indicating a decline of approximately 23.0%[34] - Operating profit for the current period is -46,970,214.23, compared to -38,694,754.71 in the previous period, reflecting a decrease of about 21.5%[34] - The total comprehensive income attributable to the parent company is -45,339,431.49, compared to -36,351,799.82 in the previous period, indicating a decline of approximately 24.5%[34] - Basic and diluted earnings per share for the current period are both -0.1426, compared to -0.1143 in the previous period, reflecting a decrease of approximately 24.8%[34] Assets and Liabilities - Total assets at the end of the reporting period were CNY 2,649,005,409.57, down 3.18% from the end of the previous year[5] - Total liabilities decreased to CNY 679,171,970.60 from CNY 721,802,602.07, a reduction of 5.9%[30] - Total assets decreased to CNY 2,649,005,409.57 from CNY 2,736,124,198.16, a decline of 3.2%[30] Cash Flow - Cash flow from operating activities for the year-to-date was CNY 2,799,122.50, down 33.89%[5] - Cash flow from operating activities netted 2,799,122.50, down from 4,233,892.91, a decrease of approximately 33.9%[37] - Cash flow from investing activities resulted in a net outflow of -10,877,335.28, compared to a net inflow of 1,965,694.10 in the previous period[37] - Cash flow from financing activities generated a net inflow of 19,883,974.42, down from 76,238,872.43, a decline of about 73.9%[37] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 11,340[23] - The largest shareholder, Liu Qun, holds 32.89% of the shares, with 35,000,000 shares pledged[23] Operating Costs and Expenses - Total operating costs amounted to CNY 415,765,238.26, down 10.0% from CNY 461,244,061.80 in the previous period[32] - Operating costs included CNY 180,545,140.47 in operating expenses, which decreased by 18.5% from CNY 221,601,767.96 in the previous period[32] - Research and development expenses decreased to 16,846,921.30 from 21,052,862.64, a reduction of about 20.0%[34] Other Income and Investments - Other income increased by 79.01% year-over-year, primarily due to a significant increase in VAT refunds[17] - Investment income decreased by 91.82% year-over-year, as there were no gains from the previous year's equity transfer settlement[17] Inventory and Receivables - Accounts receivable decreased to CNY 105,844,818.86 from CNY 120,099,455.35, a decline of 11.8%[28] - Inventory increased to CNY 110,440,316.57 from CNY 106,799,072.77, showing a growth of 3.1%[29] Prepayments and Borrowings - The company reported a 156.16% increase in prepayments compared to the beginning of the year, mainly due to increased advance payments for purchases[11] - Short-term borrowings rose to CNY 103,123,872.22 from CNY 80,080,055.56, an increase of 28.8%[30] Regulatory Issues - The company received an administrative penalty notice from the China Securities Regulatory Commission, indicating potential financial discrepancies in the annual report[26]